Inventor · disambiguated record
Daniel Bedinger
Also filed as: BEDINGER DANIEL · BEDINGER DANIEL H
16 granted patents·4 pending applications·117 citations·filing 2007–2023
92Inventor score
Top patents by PatentIndex Score
20 records- 0195US7867493B2PRLR-specific antibody and uses thereofNOVARTIS AG·Filed 2007·Granted Jan 11, 2011·61 cites·21 claims
- 0291US8569462B2Antibodies specific for TGF-beta and methods for treating thereofBEDINGER DANIEL·Filed 2012·Granted Oct 29, 2013·28 cites·21 claims
- 0387US9145458B2Antibodies specific for TGF-β and methods of treatment thereofXOMA TECHNOLOGY LTD·Filed 2013·Granted Sep 29, 2015·7 cites·24 claims
- 0486US9714285B2TGF-beta-specific antibodies and methods of use thereof for treatmentXOMA TECHNOLOGY LTD·Filed 2015·Granted Jul 25, 2017·4 cites·20 claims
- 0582US10358486B2Nucleic acids encoding, and methods of producing, antibodies specific for transforming growth factor (TGF)-βXOMA TECHNOLOGY LTD·Filed 2017·Granted Jul 23, 2019·2 cites·20 claims
- 0680US10253101B2Antibody fragments against the insulin receptor and uses thereof to treat hypoglycemiaXOMA US LLC·Filed 2016·Granted Apr 9, 2019·2 cites·33 claims
- 0780US9005614B2PRLR-specific antibody and uses thereofDAMIANO JASON·Filed 2010·Granted Apr 14, 2015·7 cites·24 claims
- 0878US12071475B2Antibodies that bind transforming growth factor beta (TGF beta) and methods of use thereof for treatmentXOMA TECHNOLOGY LTD·Filed 2021·Granted Aug 27, 2024·0 cites·19 claims
- 0975US10858428B2Antibodies that bind interleukin-2 and uses thereofXOMA US LLC·Filed 2017·Granted Dec 8, 2020·2 cites·31 claims
- 1073US2024158535A1Parathyroid hormone receptor 1(pth1r) antibodies and uses thereofXOMA US LLC·Filed 2023·Application pending·0 cites
- 1171US11098111B2Method of treating cancer by administering an antibody that binds transforming growth factor beta (TGF-beta) 1, TGF-beta 2 and TGF-beta 3XOMA TECHNOLOGY LTD·Filed 2019·Granted Aug 24, 2021·0 cites·24 claims
- 1271US10519250B2Parathyroid hormone receptor 1 (PTH1R) antibodies and uses thereofXOMA US LLC·Filed 2017·Granted Dec 31, 2019·1 cites·34 claims
- 1371US9885711B2Screening methodsWHITE MARK L·Filed 2010·Granted Feb 6, 2018·3 cites·77 claims
- 1470US11787876B2Parathyroid hormone receptor 1 (PTH1R) antibodies and uses thereofXOMA US LLC·Filed 2019·Granted Oct 17, 2023·0 cites·24 claims
- 1562US12234285B2Antibodies that bind interleukin-2 and uses thereofXOMA US LLC·Filed 2020·Granted Feb 25, 2025·0 cites·14 claims
- 1661US8546307B2Triple tag sequence and methods of use thereofRONDON ISAAC·Filed 2009·Granted Oct 1, 2013·0 cites·1 claims
- 1751US8546308B2Triple tag sequences and methods of use thereofRONDON ISAAC·Filed 2011·Granted Oct 1, 2013·0 cites·8 claims
- 1851US2018251562A1Antibody Fragments Against the Insulin Receptor and Uses Thereof to Treat HypoglycemiaXOMA US LLC·Filed 2018·Application pending·0 cites
- 1949US2018231545A1Screening MethodsXOMA TECHNOLOGY LTD·Filed 2018·Application pending·0 cites
- 2045US2015175705A1Prlr-specific antibody and uses thereofXOMA TECHNOLOGY LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daniel Bedinger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →